A new international study coordinated by the European Alzheimer’s and Dementia Biobank (EADB) consortium sheds light on how genetic risk factors for Alzheimer’s disease (AD) vary—and remain consistent—across global populations. The study represents the first worldwide examination of polygenic risk scores (PRS) and their relationship to the likelihood of developing Alzheimer’s disease.